Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
September 6, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for July 9, 2007 Subscribe to this News Feed      
 

Drug Chemist Launches Stinky Sulfur Award to Raise Health Awareness among Journalists and General Public

Dissatisfied with the drug industry's unwillingness to acknowledge natural medicine, Shane Ellison abandoned his career as a medicinal chemist to write Health Myths Exposed and The Hidden Truth about Cholesterol Lowering Drugs. Turning in his "pink slip," Shane began a pharmaceutical "sink ship" campaign. To this end, Shane is now issuing "Stinky Sulfur Awards." He asserts that these awards will save lives.

(PRWEB) July 9, 2007 -- Dissatisfied with the drug industry's unwillingness to acknowledge natural medicine, Shane Ellison abandoned his career as a medicinal chemist to write Health Myths Exposed and The Hidden Truth about Cholesterol Lowering Drugs. Turning in his "pink slip," Shane began a pharmaceutical "sink ship" campaign. To this end, Shane is now issuing "Stinky Sulfur Awards." He asserts that these awards will save lives.

To illustrate, Shane gives some moving examples. Previous award recipients would have been Merck for their pain killer Vioxx™. It was well known among scientific circles that the pain killer did more than just kill pain; according to an FDA press release, it also put people at risk for heart attack and stroke.(1) Regardless, Merck funded a publicity campaign that positioned the "COX-2" inhibitor as the safest in the history of medicine. Ellison feels that, "If the award existed during the dark Vioxx™ era, thousands could have refused the drug and avoided premature death."

In the face of an impending health crisis caused by the ubiquitous pharmaceutical industry, my Stinky Sulfur Awards are a potent weapon against dangerous drugs and medical policies.
Under Ellison's glaring and capable insider microscope, no book, no product, no person is safe from the Stinky Sulfur Award. If it stinks it wins. It's controversial. It's offensive. It's fun. And it ensures that our health does not get skunked by such stink.

A well-known author and University professor, a cholesterol-lowering drug pushing medical doctor turned commercial actor, and cheerleaders turned drug reps are among some of the recipients of the dubious award.

Shane is quick to assert that all of the recipients represent a real and present danger to the health of people worldwide. If you've ever popped an aspirin, swallowed an anti-depressant drug, been diagnosed with high-cholesterol, allowed the pediatrician to stab your kids with a vaccine, feared type II diabetes or "asked your doctor if the latest erection pill was right for you," then you better pay close attention to these awards. Visit www.thepeopleschemist.com/stinky.html

Ellison admits that not everyone is happy with the awards, especially the recipients. "While some people love the awards, others who still labor under the illusion that prescription drugs increase quality and quantity of life, oppose them," he says. But he staunchly maintains that one thing is certain. "In the face of an impending health crisis caused by the ubiquitous pharmaceutical industry, my Stinky Sulfur Awards are a potent weapon against dangerous drugs and medical policies."

Shane holds a master's degree from Northern Arizona University in organic chemistry. He founded HealthFX Nutraceuticals (www.health-fx.net) and is an internationally recognized authority on therapeutic nutrition. Get his Life Saving Health Briefs and Real Natural Cures free at www.thepeopleschemist.com

His shocking and controversial books are available at Amazon.com or www.thepeopleschemist.com.

References:

1. http://www.fda.gov/cder/drug/infopage/COX2/default.htm - Merck & Co., Inc. announced a voluntary withdrawal of Vioxx (rofecoxib) from the U.S. and worldwide market due to safety concerns of an increased risk of cardiovascular events (including heart attack and stroke) in patients on Vioxx.

2. http://www.nytimes.com/2006/08/18/business/18merck.html?ex=1182484800&en=4d9624abe1ecc091&ei=5070

3. http://money.cnn.com/2006/08/17/news/companies/vioxx/index.htm

4. http://www.medicalnewstoday.com/medicalnews.php?newsid=19251

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/Q3Jhcy1IYWxmLVByb2YtQ291cC1UaGlyLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Shane Ellison
The People's Chemist
970-375-2266
Email us Here
ATTACHED FILES

Shane Ellison
Author, Organic Chemist and Founder of Stinky Sulfur Award

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright